ArticleFrontiers in neurology2022

Long-Term Improvement in a Chinese Cohort of Glucocorticoid-Resistant Childhood-Onset Myasthenia Gravis Patients Treated With Tacrolimus.

Zhuajin Bi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.